George Elston Net Worth & Insider Trades

George Elston - Chief Financial Officer, Eyepoint Pharmaceuticals, Inc

As of October 17, 2023

What is George Elston's Net Worth?

The current estimated net worth of Eyepoint Pharmaceuticals, Inc's Chief Financial Officer, George Elston, is estimated to be about $932.95M . George Elston owns about 40,000 units of Eyepoint Pharmaceuticals, Inc common stock. In the last 4 years at Eyepoint Pharmaceuticals, Inc, George Elston has sold an estimated value of $17.43K worth.

What is George Elston's Past Insider Trading?

George Elston's largest purchase order was 10,000 units , worth over $14.29K on November 18, 2019. In total, George Elston has made about 12 transactions over 4 years of their time at Eyepoint Pharmaceuticals, Inc. George Elston usually trades in March, June and February, with the busiest year in 2023. The most recent transaction was a purchase order of 10,000 units , worth over $4.8K on September 9, 2020.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

George Elston

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What was George Elston's Salary in 2020?

As Chief Financial Officer of Eyepoint Pharmaceuticals, Inc, George Elston has a total base salary of $440,000 . George Elston received compensation valued at about $775,704 in 2020 after becoming Chief Financial Officer. The vast majority of their compensation came in the form of option awards of $83,104 , other earnings, plans or compensations of $236,940 , and other compensation of $15,660 .

What is George Elston's' Mailing Address?

  • Mailing address is 124 Chatham Street Chatham NJ 07928 NJ

Eyepoint Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Nancy Lurker 2020 $581,957 - $482,460 $563,216 $454,508 $15,660 $2,097,801
Nancy Lurker 2019 $577,037 - $650,207 $693,165 $144,034 $15,340 $2,079,783
George Elston 2020 $440,000 - - $83,104 $236,940 $15,660 $775,704
George Elston 2019 $58,385 $20,000 - $635,555 - $2,068 $716,008
Dario Paggiarino 2020 $436,156 - $158,864 $185,417 $242,371 $15,660 $1,038,468
Dario Paggiarino 2019 $420,862 - - $275,775 $105,188 $15,340 $817,165
Scott Jones 2020 $376,250 - $158,864 $185,417 $212,135 $15,660 $948,326
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1314102/000156459021022639/eypt-def14a_20210622.htm

What are Eyepoint Pharmaceuticals, Inc's Past Insider Trades?

Eyepoint Pharmaceuticals, Inc's most recent insider trade came on September 6, 2023 by Ew Healthcare Partners Lp, Ew Healthcare Partnersa Lp, Essex Woodlands Fund Ixgp Lp and Essex Woodlands Ix Llc who sold 20,000 units worth $197.98K . In the last 5 years, insiders at Eyepoint Pharmaceuticals, Inc have sold an estimated value of $9.08M and bought an estimated value of $22.04M worth of shares. Insider trading is most common in June, with the busiest year in 2023. The most active traders at the company are Nancy Lurker, Executive Vice Chair,  Dario Paggiarino, Chief Medical Officer,  and Jay Duker, President and CEO .

EyePoint Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...